Inovio Pharmaceuticals, today announced that it has inked an agreement providing ApolloBio with the exclusive right to d...
Pfizer and Astellas Pharma announced that a supplemental New Drug Application (sNDA) for XTANDI (enzalutamide) has been ...
Biogen recently announced that it has inked an agreement to acquire investigational candidate for schizophrenia from Pfi...
Korea’s JW Pharmaceutical, a subsidiary of JW Holdings, announced that it has developed a tablet formulation of Du...
Globally, the radiopharmaceutical medicine market is expected to reach USD 13.8 billion by 2024, according to a new repo...
A biologically-based alternative HIV treatment developed in Taiwan and manufactured in China has won approval from the U...
Singapore- Prometic Life Sciences Inc. announced that the U.S Food and Drug Administration (FDA) has granted a Rar...
Novo Nordisk, the world’s largest diabetes drugmaker has presented the first successful data from a large final-st...
A WuXi AppTec group company, STA Pharmaceutical Co., the leading open-access capability and technology platform for smal...
Orphan diseases, once rare, are now affecting larger populations, with one in every 5000 people suffering from a rare ge...
China based biotechnology company NetVation DL Medicine has entered into a two-year research collaboration with Pfizer I...
Singapore - A recent study observed a connection between male-pattern baldness, when it occurs at a young age, and the s...
Computation-driven pharmaceutical technology company XtalPi Inc. has closed a Series B funding round of $15 million led ...
Taiwan-based biopharma company OBI Pharma announced that it has received the US FDA nod for an investigational new drug ...
Singapore - Forty Seven, a US based clinical-stage company focused on developing the next generation of transformational...
Singapore - The U.S. Food and Drug Administration expanded the approved use of Lynparza (olaparib tablets) to include th...
Telix Pharmaceuticals , an Australian biopharmaceutical company focused on the development of diagnostic and therapeutic...
A clinical –stage biopharmaceutical company BerGenBio ASA has announced that the first efficacy endpoint has been ...
